{"id":"W4322766543","doi":"10.1016/j.ejps.2023.106418","title":"Pharmacokinetics and pharmacodynamics of imatinib for optimal drug repurposing from cancer to COVID-19","year":2023,"lang":"en","type":"article","venue":"European Journal of Pharmaceutical Sciences","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Infection and Immunity","funders":"Innovative Medicines Initiative; European Commission; Innovative Health Initiative; European Federation of Pharmaceutical Industries and Associations","keywords":"Pharmacokinetics; Repurposing; Pharmacodynamics; Coronavirus disease 2019 (COVID-19); Drug repositioning; Pharmacology; Imatinib; Medicine; 2019-20 coronavirus outbreak; Drug; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Virology; Internal medicine; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001271997,0.0003661189,0.001254945,0.0002218219,0.0001472906,0.0006422465,0.0002768937,0.0003939342,0.001212726],"category_scores_gemma":[0.002670224,0.000237319,0.0007892355,0.0002228243,0.0003837334,0.0004436295,0.0003129277,0.0008699794,0.0001678088],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005374341,"about_ca_system_score_gemma":0.0004470678,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003159452,"about_ca_topic_score_gemma":0.0004254447,"domain_scores_codex":[0.9994093,0.0002939618,0.0000366256,0.0001013327,0.00009278465,0.00006599375],"domain_scores_gemma":[0.9991511,0.0003451167,0.0002628596,0.00005819764,0.0000253538,0.0001573838],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.5579697,0.005335478,0.1208125,0.0006606433,0.002510858,0.0004142124,0.0002647781,0.01039662,0.1351501,0.0007357873,0.001465229,0.1642841],"study_design_scores_gemma":[0.0403439,0.2772418,0.591755,0.00008520799,0.002435792,0.001814477,0.0001680047,0.04050745,0.03823284,0.001014534,0.006265537,0.0001354835],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978294,0.001364981,0.0003994752,0.00005451642,0.00001149741,0.00005061722,0.00008948262,0.00001321371,0.0001868027],"genre_scores_gemma":[0.9989568,0.0002791426,0.0003001811,0.00005731636,0.00001491022,0.00003794361,0.0002164077,0.000003791819,0.0001334709],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001271997,"threshold_uncertainty_score":0.00672704,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1048869937484054,"score_gpt":0.4440031862422961,"score_spread":0.3391161924938906,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}